Navigation Links
Landauer, Inc. Appoints Two New Members to Board of Directors
Date:8/29/2008

GLENWOOD, Ill., Aug. 29 /PRNewswire-FirstCall/ -- Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation monitoring, today announced the appointment of Michael Leatherman and David Meador to its Board of Directors.

Mr. Leatherman, currently an independent consultant focused in information technology strategies and global contract negotiations, was previously the Chief Financial Officer, Chief Information Officer and Executive Vice President at Wallace Computer Services. Leatherman was primarily responsible for information technology, strategic planning, and organizational effectiveness. Prior to his time at Wallace Computer Services, Leatherman spent six years at FSC Paper Corporation acting as both the Chief Executive and Financial Officers. He has acted as a Smorgon Consolidated Industries board member from 1984 to 2000 and has been a Nashua Corporation board member since 2006.

Mr. Meador currently serves as the Chief Financial Officer and Executive Vice President at DTE Energy (NYSE: DTE), a diversified energy company involved in the development and management of energy-related businesses and services nationwide. Meador is responsible for investor relations, treasury, business taxes and financial forecasting, accounting, corporate services and supply chain management. Meador joined DTE Energy in 1997 as Vice President and Controller. Prior to his employment with DTE Energy, he served in a variety of financial and accounting positions at Chrysler Corporation and was an auditor with Coopers & Lybrand.

"We are pleased to announce the appointment of Michael and David to our board, as both have a tremendous track record of innovative leadership, success and extensive financial experience," commented Bob Cronin, Chairman of the Board of Landauer. "They will be valuable additions to our Board and we look forward to their contributions as we continue to execute on our strategic objectives and pursue opportunities for the Company."

About Landauer

Landauer is the leading provider of analytical services to determine occupational and environmental radiation exposure. For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings.


'/>"/>
SOURCE Landauer, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2008 Results
2. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
3. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
4. UltraShape Appoints Assaf Eyal as President & CEO
5. RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
6. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
7. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
8. WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
9. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
10. RainDance Technologies Appoints Olex Vice President, System Development
11. Omeros Appoints David A. Mann to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 22, 2017  PrimeVax Immuno-Oncology, Inc. announced today its ... the Annual Biocom Global Life Science Partnering Conference.  The ... AM, at the Torrey Pines Lodge, in San Diego.  ... at Biocom who have chosen our company, amongst numerous ... companies, investors, and clinical researchers," said Mr. Chen. "In ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... and development of precision treatments for neurodegenerative diseases, today announced it has issued ... ProMIS approach.” This is one of a series of commentaries from ProMIS’s scientific ...
(Date:2/22/2017)... , Feb 22, 2017 Dublin ... the "Global Biological Crop Protection (Bio-Pesticide) Market-By Type, By Application, ... report to their offering. ... Global Biological Crop Protection Market is forecasted to ... The strong growth in biopesticide or biological crop protection market is ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... Spyker, PhD, MD former Acting Deputy Director in the FDA CDRH Division of ... Staff has joined the company as an Expert Consultant. , In Dr. Spyker’s ...
Breaking Biology Technology:
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
(Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
Breaking Biology News(10 mins):